Here are six key updates from Johnson & Johnson’s orthopedic business in 2025: 1. Johnson & Johnson is planning to separate its orthopedic business, which will operate as DePuy Synthes. Namal Nawana, ...

A blockbuster international deal announced Wednesday, in which New Jersey-based health products giant Johnson & Johnson has agreed to buy medical device maker Synthes for $21.3 billion, could have a ...

Johnson & Johnson plans to spin off its orthopedics business into a standalone company. The move comes as part of a bid to focus J&J’s medical technology division on faster-growing areas. In an Oct.

Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

Now that they've completed their stints in federal prison, four former Synthes executives have been essentially banished from the healthcare industry for their roles in the Norian bone cement scandal ...

PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

Johnson & Johnson MedTech has secured an FDA 510(k) clearance for its first robotically guided platform for spine surgery and has slated its commercial launch for the first half of next year. The ...

I write about the rapidly evolving artificial intelligence technology and its possible impacts on society. Originally from England, I spent some time at the BBC in London before moving to Switzerland ...

ZURICH (Reuters) - Swiss medical device maker Synthes posted a 24 percent rise in net profit to $348.8 million in the first-half of the year as high demand across all regions and product lines boosted ...

TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...